Expert consensus on administering oncolytic viruses for gynecological cancers in China

Journal of Cancer Metastasis and Treatment · Published 2026-05-29 · DOI 10.20517/2394-4722.2025.151

Free full text

Authors (7)

Lele Zang, Qiying Zhang, Xiaomei Fan, Jing Liu, Xiang Zhang, Ke Zhang, Qin Xu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Zang, L., Zhang, Q., Fan, X., et al. (2026). Expert consensus on administering oncolytic viruses for gynecological cancers in China. Journal of Cancer Metastasis and Treatment. https://doi.org/10.20517/2394-4722.2025.151

Related articles

• Optimal approach to stem cell mobilization in transplant-eligible multiple myeloma patients · Journal of Cancer Metastasis and Treatment · 2024 · Same journal
• A serum three-microRNA panel: promising biomarkers for renal cell carcinoma screening · Journal of Cancer Metastasis and Treatment · 2025 · Same journal
• Renin-angiotensin-system and clear cell renal carcinoma: research advances and future perspectives · Journal of Cancer Metastasis and Treatment · 2024 · Same journal
• Knockdown of the EEF1A2 gene reduces lung cancer brain metastasis by downregulating the BCL10/NFκB pathway · Journal of Cancer Metastasis and Treatment · 2025 · Same journal
• Emerging surgical optimization strategies for early-stage cervical cancer: insights from global evidence and Chinese research contributions · Journal of Cancer Metastasis and Treatment · 2026 · Same journal
• Factors associated with prognosis and staging of intrahepatic cholangiocarcinoma · Journal of Cancer Metastasis and Treatment · 2024 · Same journal
• Lung metastasis in soft tissue sarcomas: survival and risk factors using the SEER database · Journal of Cancer Metastasis and Treatment · 2025 · Same journal
• Censor-aware semi-supervised survival time prediction in lung cancer using clinical and radiomics features · Journal of Cancer Metastasis and Treatment · 2025 · Same journal
• Perioperative therapies for metastatic renal cell carcinoma · Journal of Cancer Metastasis and Treatment · 2025 · Same journal
• The lnc-MAPKAPK5-AS1 promotes colon cancer-derived liver metastasis via modulating the tumor microenvironment: an in silico study and immunohistochemistry validation · Journal of Cancer Metastasis and Treatment · 2025 · Same journal